Eclampsia Warning Signs and the Seizures That Give None
Most eclamptic seizures announce themselves first. A meaningful share do not. Both of those statements come from the same published source, and holding them at the same time is the whole clinical skill.
How eclampsia is defined
ACOG Practice Bulletin No. 222 defines eclampsia as new onset tonic clonic, focal, or multifocal seizures in the absence of other causes. The absence clause is not filler. It is part of the definition.
Three seizure descriptions, one exclusion requirement. Read the definition that way and it stops being vague.
The other causes that have to be excluded
The bulletin names what has to be ruled out: epilepsy, cerebral ischemia or infarction, intracranial hemorrhage, and drug use. A pregnant patient who seizes does not automatically have eclampsia.
So a stem that mentions a known seizure disorder, or a stroke history, or a substance in the history, has handed you a competing explanation on purpose. That detail is doing work.
The exam rewards you for noticing it rather than pattern matching from pregnancy plus seizure straight to a diagnosis.
Why the exclusion clause changes the answer
The definition asks you to establish an absence, which is unusual and worth pausing on. Most diagnostic criteria list what must be present. This one also lists what must be absent.
The practical effect is that a seizure in a pregnant patient is a question rather than an answer. Epilepsy is common. Strokes happen in pregnancy. Substances are part of some patients' lives, and none of that stops being true at 32 weeks.
So an item that hands you a seizure and a competing explanation is testing whether you will jump. A known seizure disorder does not rule this diagnosis out either, which is the second half of the same trap.
Read the whole history. Then decide what this seizure most likely is.
Most cases give a warning
Here is the figure worth knowing. The same bulletin reports that 78 to 83% of eclampsia cases are preceded by premonitory signs.
That is a strong majority. It is the reason those symptoms are asked about at every visit, and the reason an item that plants one of them in a stem is pointing directly at risk.
Which warning signs are named
Four are listed by name. Severe persistent headache. Blurred vision. Photophobia. Altered mental status.
Notice what they have in common. Every one of them is neurologic, and every one of them is something the patient reports rather than something a machine measures. A headache that will not lift is not a comfort complaint in this population. It is a finding.
This is also where severe features overlap. New cerebral or visual disturbance appears on the published severe features list, and how that list changes management is worked through in severe features and the shortcut for 160 over 110.
And a substantial minority give none
The same bulletin is explicit that eclampsia can occur with no warning at all. A UK national analysis it cites found that 38% of eclamptic seizures occurred in patients with no previously documented hypertension or proteinuria.
Sit with that number. It counts patients with no hypertension or protein recorded beforehand, rather than patients who reported no symptoms, and nearly two in five sat there.
This is the half of the picture that pure pattern learning erases. If you have trained yourself to expect a headache before a seizure, a stem describing a first seizure in a patient with an unremarkable record will not read as eclampsia to you, and it should.
The reverse error costs just as much. A patient with textbook warning signs who is reassured because her pressure looks acceptable today has been read through the wrong lens as well. Neither the symptoms nor the numbers get to veto the other one.
Eclampsia is not the inevitable endpoint
Study material often draws preeclampsia as a conveyor belt that ends in a seizure. The published figures do not support that shape.
In placebo controlled trials cited in the bulletin, seizures occurred in 1.9% of untreated patients with preeclampsia and in 3.2% of those with severe preeclampsia. Those are real risks. They are not a majority, and they are not a march.
The practical consequence is a calmer kind of vigilance. Preeclampsia is treated seriously because the outcome is severe, not because it is common, and a patient with preeclampsia is not a patient who is about to seize.
A worked stem
A patient at 36 weeks with preeclampsia reports a headache that has not responded to anything since yesterday, and she has been photophobic since this morning. Her pressure is 158 over 104 mmHg.
Two named premonitory signs sit in that sentence. She belongs to the group where 78 to 83% of cases were preceded by warning, and the warning has now been given.
Take a different patient. She is 37 weeks, has no recorded hypertension, has attended every visit, and seizes in the waiting room. Nothing in the published figures makes that impossible, and the cited national analysis puts nearly two in five eclamptic seizures in exactly that situation.
Both patients have the same diagnosis arriving through different doors.
What this does to your reading of a stem
Two habits fall out of these numbers. First, treat a named premonitory symptom as a finding that changes urgency, because most cases have one. Second, do not require a premonitory symptom before you will consider the diagnosis, because a large minority never had one.
Seizure prophylaxis is where this usually goes next, and the monitoring that comes with it has three parts and one widely misquoted figure. Those are set out in magnesium sulfate monitoring and the nursing triad.
After the seizure, the risk moves
A patient who has seized is still pregnant or newly delivered, and the risk profile shifts rather than ends. Blood loss after delivery has its own published ranking of causes, laid out in postpartum hemorrhage and the four Ts, ranked by frequency.
Fetal status is the other half of the picture during and after a seizure, and the three tier system used to describe a tracing is explained in fetal heart rate categories one, two and three.
The two numbers to carry
Between 78 and 83% of cases preceded by premonitory signs. Thirty eight percent, in the cited national analysis, with no hypertension or proteinuria documented beforehand. Those two figures count different things, so neither cancels the other, and an exam item can be built on either one. One more framing helps. Warning signs raise your suspicion, and their absence lowers it very little.
Where these obstetric items sit inside the larger exam is mapped in maternity and newborn questions and what is really being tested.